Register
Formulation Development

Latest Headlines
Xcelience and IriSys business alliance agreement strengthens regional access to CMC/Regulatory expertise
More...
Xcelience Adds Piccola B10 Minipress for GMP Tablet Formulation Development in Experimental Area
More...
Xcelience and Penn Pharma Form a Joint Venture to Provide API Into Capsule Services in Europe and Asia Pacific Markets
More...





Featured Publication
Recent Options for Phase 1 Formulation Development and ClinicalTrial Material Supply. By: Balaji V. Kadri - Featured in the August 2008 Issue of Pharmaceutical Technology



Case Studies

Case Study 3
Re-formulation and Process Improvement of a Labor Intensive and Expensive Manufacturing Process



The original process involved wet granulation and sugar coating and took approximately one-week to manufacture.  The resultant product yielded varying dissolution profiles.


API comprises approximately 40% of the tablet.  Initial direct compression resulted in poor weight uniformity and capping problems.


Xcelience statistically optimized the ingredients and their amounts to produce an elegant product which was successfully transferred to the manufacturing facility.


The reformulated product uses a direct compression and aqueous film coated process.  It takes approximately 1.5 days to manufacture and yields a robust, rugged product, with reproducible and stable physical and chemical properties











Home | Services | Corporate | Publications | Equipment List | Resources | News | Career | Contact


Drug Development Services | Pharmaceutical Pre-Formulation Development | Pharmaceutical Formulation Development
Drug Development Analytical Method | Xcelodose Drug Manufacturing | Drug Delivery Expert Consulting | BOOKMARK US

Copyright © 2010 Xcelience All rights reserved.
Website Designed by GI & Hi-Tech - Tampa, FL